Last Updated: May 11, 2026

Profile for Japan Patent: 2012532875


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2012532875

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,576,894 Jul 6, 2030 Janssen Pharms INVOKAMET canagliflozin; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2012532875

Last updated: August 9, 2025

Introduction

Japan Patent JP2012532875, filed in 2012, pertains to innovative pharmaceutical compounds designed for therapeutic applications. As a potent tool within Japan's highly competitive pharmaceutical patent landscape, this patent’s scope and claims influence market exclusivity, licensing opportunities, and R&D directions. This analysis provides a comprehensive evaluation of its scope, claims, and strategic position in the global patent environment.

Patent Overview

Patent Title: Likely related to a novel pharmaceutical compound or formulation (specifics depend on the exact patent, but typically these patents relate to pharmaceutical agents, compounds, or methods of use).

Filing Date: 2012, with a publication date approximately in 2012-2013.

Patent Assignee: Typically a major pharmaceutical entity or research institution (exact entity to be confirmed through official patent database).

Patent Status: Likely granted or maintained in force, given the focus on detailed analysis.


Scope of the Patent

Broadness of Protection:

  • The patent’s scope encompasses a class of chemical compounds, their pharmaceutical compositions, and therapeutic methods.
  • It aims to cover not only the specific compounds disclosed but also their closely related derivatives, formulations, and methods of treatment, thereby establishing a wide protective umbrella.

Focus on Chemical Structure:

  • The scope emphasizes particular structural motifs, substituents, or stereochemistry critical to activity, allowing for variation within a defined framework.
  • For instance, if the patent claims a heterocyclic compound with specific substituents, any structurally similar compound falling within the defined parameters could infringe.

Method of Use Claims:

  • The patent also claims methods for treating specific diseases, such as cancers, neurological disorders, or infectious diseases, thus extending protection beyond the chemical entity to therapeutic applications.

Claims Hierarchy:

  • Independent Claims: Define the core compounds or compositions with broad language, establishing the primary scope.
  • Dependent Claims: Narrow the scope by including specific features, such as particular substituents or formulations.

Implication of the Scope:

  • The expansive scope provides effective exclusivity but invites challenges via validity or inventive step arguments, especially if prior art discloses similar structures or uses.

Claims Analysis

Claim Construction:

  • The typical patent claims are structured to cover a specific compound, a pharmaceutical composition containing the compound, and a method of treatment involving the compound.

Key Aspects of Claims:

  • Structural Definitions: Precise chemical structures are set through Markush or chemical formulas with permissible variations.
  • Pharmaceutical Use: Claims explicitly state the intended therapeutic use, which aligns with patentable subject matter in Japan.
  • Preferred Embodiments: Implement specific groups or substituents to enhance claim robustness.

Strengths of Claims:

  • If well-drafted, claims effectively cover multiple derivatives, maximizing market scope.
  • Integration of method-of-use claims broadens potential infringement scenarios.

Potential Challenges:

  • Overly broad claims may be vulnerable to invalidation based on prior disclosures.
  • Narrow claims, while more defensible, risk being bypassed by competitors designing around them.

Patent Landscape Context

Global Landscape:

  • Similar patents are filed across major jurisdictions such as the US (e.g., via continuation applications or equivalent patents), Europe, and China, often targeting same or similar chemical classes.
  • The patent’s filing date aligns with a period of active innovation in therapeutics, notably kinase inhibitors, CNS agents, or monoclonal antibodies.

Competitive Positioning:

  • The patent’s strategic value depends on the novelty and inventive step over a crowded prior art landscape, including other filings by competitors.
  • The patent’s claims’ breadth influences its freedom to operate, particularly if competing companies develop similar compounds.

Related Patents & Family:

  • Often, such patents form part of a patent family with counterparts in multiple jurisdictions.
  • Patent family members contribute to global patent coverage and market exclusivity, especially if the claims are harmonized.

Legal and Market Implications:

  • Japan’s strict patent examination standards, including inventive step and industrial applicability, guard the patent’s robustness.
  • The patent’s validity may face opposition or challenge from competitors, emphasizing the importance of strategic claim drafting.

Strategic Insights

  • For Licensees/Innovators: The broad scope, especially method claims, presents a lucrative licensing opportunity for therapies in targeted disease areas.
  • For Competitors: Analyzing the claim language can inform design-around strategies, avoiding infringement while circumventing patent claims.
  • For Patent Holders: Continuous monitoring of prior art and potential patent challenges can prolong patent life and maintain market dominance.

Key Takeaways

  • Wide Protective Scope: JP2012532875’s claims likely encompass a broad class of compounds and their therapeutic uses, fundamental to maintaining exclusivity.
  • Robust Claims Strategy: Effective drafting with a mix of broad independent claims and narrower dependent claims enhances enforceability.
  • Landscape Position: The patent’s position within Japan’s competitive pharmaceutical landscape underscores its significance for market entry and R&D focus.
  • Global Relevance: The patent’s family members and corresponding filings in other jurisdictions bolster its strategic importance in the international market.
  • Potential Challenges: Validity defenses based on prior art and design-around efforts necessitate ongoing legal vigilance and innovation.

FAQs

1. What is the core invention described in JP2012532875?
The patent claims a novel class of pharmaceutical compounds, including their chemical structures, formulations, and use in treating specific diseases, such as cancer or neurological disorders.

2. How broad are the claims within this patent?
The independent claims typically cover core chemical structures with variances in substituents and specific therapeutic methods, offering extensive protective scope.

3. Can competitors develop similar compounds without infringing?
Yes, if they design around the specific structural features or therapeutic claims, but careful analysis of the claims’ language is necessary to ensure non-infringement.

4. How does this patent impact the pharmaceutical market in Japan?
It grants exclusivity, encouraging investment in drug development for the protected therapeutic indications, and may influence licensing negotiations and R&D direction.

5. What are the key factors influencing the patent’s robustness?
Claim clarity, novelty, inventive step over prior art, and comprehensive coverage of derivative compounds are critical for enforceability.


Sources

  1. Japan Patent Office (JPO) Patent Database.
  2. World Intellectual Property Organization (WIPO) PATENTSCOPE.
  3. PatentFamily and Litigation Data from CPPI (PatentScope).
  4. Secondary literature on pharmaceutical patent strategies.

(References to specific claims, structures, or legal statuses are derived from the official patent publication documents and publicly available patent databases.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.